Price: $9.52
· 1 day: +17.39% · 5 days: +24.77% · 1 month: +70.00% · YTD: -54.67%
As of 2026-10-15 20:00 UTC.
52-week range: $4.51 – $69.0 (currently at 8% of the range).
The brief
RGC is in a turning down, momentum firm. $10 is the level overhead; $9 the first support below.
4 of 6 technical checks lean bullish.
Price vs 50-day: above
Price vs 200-day: below
50d vs 200d avg: below
MACD: bullish
RSI momentum: 84
5-day tape: +24.8%
Trend
Turning down · above 50-day & below 200-day
Momentum
RSI 83.57 · neutral · MACD bullish
Trend strength
ADX 45.2 · strong trend
Location
+55.1% vs 50-day MA
52-week range
-82% from high · +99% from low
Volatility
ATR 0.93 · ~9.8%/day
Key levels
Level
Type
Distance
$10.0 (resistance)
round
5.04%
$11.0 (resistance)
round
15.55%
$18.56 (resistance)
sma 200
94.96%
$9.0 (support)
round
-5.46%
$8.0 (support)
round
-15.97%
$6.35 (support)
swing zone
-33.3%
Indicators
RSI (14)
83.57
MACD
0.6262
ADX (14)
45.2
ATR (14)
0.93
50-day average
$6.14
200-day average
$18.56
Next earnings: 2026-10-28.
Latest RGC news
Council Post: Healthcare's AI Advantage Won't Come From Automation — The article argues that AI's primary value in healthcare will shift from administrative automation to augmenting clinical expertise, as automation becomes commoditized. It highlights the growing supply-demand gap for spe (Forbes, 2026-09-28)
CentralReach Launches ReportDraftAI to Cut the Manual Work Behind ABA Reports — CentralReach announced the general availability of ReportDraftAI, an AI-assisted tool that automates ABA report drafting by integrating authorization, clinical, and progress data into a review-ready draft. The product ta (PR Newswire, 2026-09-22)
Elevance Stock Falls on Medicaid Concerns — Elevance Health shares declined 10% on Wednesday amid broader weakness in managed care stocks, with competitors Centene and Molina also trading lower. The sector is facing pressure from declining enrollment in Affordable (The Wall Street Journal, 2026-07-15)